Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Conversion of Stock, Amount Converted

2.8 / 5 stars · 68/120 Roast Me

BRAINSTORM CELL THERAPEUTICS INC. Conversion of Stock, Amount Converted

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Conversion of Stock, Amount Converted of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-29.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:ConversionOfStockAmountConverted1 · last filed 2017-03-29

  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for the quarter ending 2016-12-31 was $0.00.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for the quarter ending 2016-09-30 was $0.00.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for the quarter ending 2016-06-30 was $0.00.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for fiscal 2015 was $130.00K.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for fiscal 2014 was -$42.00K.
  • BRAINSTORM CELL THERAPEUTICS INC. conversion of stock, amount converted for fiscal 2013 was $0.00.
Period endConversion of Stock, Amount Converted 3 monthConversion of Stock, Amount Converted 3 month as first filedConversion of Stock, Amount Converted 6 monthConversion of Stock, Amount Converted 6 month as first filedConversion of Stock, Amount Converted 9 monthConversion of Stock, Amount Converted 9 month as first filedConversion of Stock, Amount Converted 12 monthConversion of Stock, Amount Converted 12 month as first filed
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29
$0.00
derived: sum of 2 quarters · filed 2017-03-29
$0.00
derived: sum of 3 quarters · filed 2017-03-29
$0.00
10-K · filed 2017-03-29
2016-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 4 quarters · filed 2017-03-29
2016-06-30$0.00
10-Q · filed 2016-08-11
$0.00
10-Q · filed 2016-08-11
$0.00
derived: sum of 3 quarters · filed 2017-03-29
$0.00
derived: sum of 4 quarters · filed 2017-03-29
2016-03-31$0.00
10-Q · filed 2016-05-10
$0.00
derived: sum of 2 quarters · filed 2017-03-29
$0.00
derived: sum of 3 quarters · filed 2017-03-29
$0.00
derived: sum of 4 quarters · filed 2017-03-29
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29
$0.00
derived: sum of 2 quarters · filed 2017-03-29
$0.00
derived: sum of 3 quarters · filed 2017-03-29
$130.00K
10-K · filed 2017-03-29
-$130.00K
10-K · filed 2016-03-09
2015-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$130.00K
10-Q · filed 2016-11-14
-$130.00K
10-Q · filed 2015-11-16
$130.00K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$0.00
10-Q · filed 2016-08-11
$130.00K
10-Q · filed 2016-08-11
$130.00K
derived: sum of 3 quarters · filed 2016-08-11
$130.00K
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$130.00K
10-Q · filed 2016-05-10
$130.00K
derived: sum of 2 quarters · filed 2016-05-10
$130.00K
derived: sum of 3 quarters · filed 2016-05-10
$172.00K
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09
$0.00
derived: sum of 2 quarters · filed 2016-03-09
$42.00K
derived: sum of 3 quarters · filed 2016-03-09
-$42.00K
10-K · filed 2016-03-09
$42.00K
10-K · filed 2015-03-26
2014-09-30$0.00
10-Q · filed 2015-11-16
$42.00K
derived: sum of 2 quarters · filed 2015-11-16
-$42.00K
10-Q · filed 2015-11-16
$42.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$42.00K
10-Q · filed 2015-08-13
-$42.00K
10-Q · filed 2014-08-12
$42.00K
10-Q · filed 2015-08-13
-$42.00K
10-Q · filed 2014-08-12
$42.00K
derived: sum of 3 quarters · filed 2015-08-13
$42.00K
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31$0.00
10-Q · filed 2015-05-14
$0.00
derived: sum of 2 quarters · filed 2015-05-14
$0.00
derived: sum of 3 quarters · filed 2015-05-14
$0.00
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26
$0.00
derived: sum of 2 quarters · filed 2015-03-26
$0.00
derived: sum of 3 quarters · filed 2015-03-26
$0.00
10-K · filed 2015-03-26
2013-09-30$0.00
10-Q · filed 2014-11-13
$0.00
derived: sum of 2 quarters · filed 2014-11-13
$0.00
10-Q · filed 2014-11-13
2013-06-30$0.00
10-Q · filed 2014-08-12
$0.00
10-Q · filed 2014-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37